Mayo Clinic Proceedings reviews deep brain stimulation to treat psychiatric diseases
ROCHESTER, Minn. Pioneering therapeutic trials to investigate the effectiveness of deep brain stimulation (DBS) in hard-to-treat depression, obsessive-compulsive disorder (OCD) and Tourette's syndrome are underway at multiple medical centers around the world, according to a review in the June 200...First Brain Training Consumer's Guide Debunks Ten Brain Health Myths and Reviews 21 Products
New Guide to be Unveiled by SharpBrains CEO on June 11th, during Games for Health Conference in Boston, MA SAN FRANCISCO, June 9 /PRNewswire/ -- How can you take care of your brain when every week brings a new barrage of articles and studies which seem to contradict each other? Do supplement...Free Community Seminar; Reviews Treatment Options for Enlarged Prostate
Supporting men's health awareness by exploring solutions to the most common health problem for men over the age of 60 ROSEMEAD, Calif., March 31 /PRNewswire/ -- The causes and treatments of enlarged prostate will be the focus of a free community seminar on April 2, 2009 at 6:30pm at the Doubl...New BSI CE-Onsite Facilitates CE Marking Reviews for Device Manufacturers
RESTON, Va., March 26 /PRNewswire/ -- As a direct response from client feedback, BSI launches a new speed-to-market program, CE-Onsite FastTrack Review, for Class III medical devices needing European CE Marking Design Dossier Reviews. This new program will expedite the review process through live,...Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases
ROCHESTER, Minn., June 29 /PRNewswire-USNewswire/ -- Pioneering therapeutic trials to investigate the effectiveness of deep brain stimulation (DBS) in hard-to-treat depression, obsessive-compulsive disorder (OCD) and Tourette's syndrome are underway at multiple medical centers around the worl...Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day
Pivotal Trial Expected to Initiate in 2010 for Blinatumomab NEW YORK, April 24 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today held an R&am...Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer
IRVING, Texas--(BUSINESS WIRE)--Apr 25, 2007 - Reata Pharmaceuticals, Inc. today announced the publication of a review article covering the company's Synthetic Triterpenoid programs in the May 2007 issue of the prestigious journal "Nature Reviews Cancer." The article, "Triterpenoids and rexinoids ...Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
PHILADELPHIA, June 25, 2007 /PRNewswire-USNewswire/ -- Childhood cancers are fortunately rare, but among them, neuroblastoma is a special case, accounting for 7 percent of all childhood cancers, but 15 percent of childhood cancer deaths. It typically occurs as a solid tumor in the abdomen, but als...Project Zero Delay Accelerates Drug's Path to Clinical Trial
...ished before the FDA's ruling included budget and contract negotiations, site visits and preparation, training and a series of mandatory institutional reviews at M. D. Anderson. "M.D. Anderson and AstraZeneca share a common goal of using leading edge science to deliver medicines that will benefit pati...Cochrane Reviews in Eyes and Vision
Description: Cochrane Reviews enable all those involved with healthcare decisions to keep up to date with the very latest evidence in their field of interest - a challenge which becomes harder each year as the volume of evidence increases. Cochrane Reviews solve this problem by delivering the best single source...Cochrane Reviews in Musculoskeletal Injuries
Description: Cochrane Reviews enable all those involved with healthcare decisions to keep up to date with the very latest evidence in their field of interest - a challenge which becomes harder each year as the volume of evidence increases. Cochrane Reviews solve this problem by delivering the best single source...Cochrane Reviews in Musculoskeletal
Description: Cochrane Reviews enable all those involved with healthcare decisions to keep up to date with the very latest evidence in their field of interest - a challenge which becomes harder each year as the volume of evidence increases. Cochrane Reviews solve this problem by delivering the best single source...Cochrane Reviews in Prostatic Diseases and Urologic Cancers
Description: Cochrane Reviews enable all those involved with healthcare decisions to keep up to date with the very latest evidence in their field of interest - a challenge which becomes harder each year as the volume of evidence increases. Cochrane Reviews solve this problem by delivering the best single source...Cochrane Reviews in Incontinence
Description: Cochrane Reviews enable all those involved with healthcare decisions to keep up to date with the very latest evidence in their field of interest - a challenge which becomes harder each year as the volume of evidence increases. Cochrane Reviews solve this problem by delivering the best single source...Biophysical Reviews makes debut in 2009
The International Union for Pure and Applied Biophysics (IUPAB) and Springer will launch the journal Biophysical Reviews in spring 2009. Biophysical Reviews is the new official journal of the IUPAB, the leading international biophysics organization consisting of 52 national societies with app...Sirtris' review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
CAMBRIDGE, MA [October 1, 2008] Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it published a new review article on the growing body of sirtuin research and its potential to treat diseases ...AGU journal highlights -- Aug. 6, 2009
... dimming," this phenomenon has been countered in the past few decades by "global brightening" as pollution control efforts have met with success. Wild reviews the evidence surrounding global dimming and brightening, addressing a number of frequently asked questions such as how and when dimming and brightenin...K-State researchers say after-school programs should promote activity, healthy nutrition
...published in numerous publications, including in the Journal of Sport and Exercise Psychology , Journal of Physical Activity and Health , Nutrition reviews and Journal of School Health . Preliminary outcomes were presented at the 2009 American College of Sports Medicine annual meeting in Seattle, Wash. ...ADA releases position paper on food and water safety
...iation has released an updated position paper on food and water safety that reviews the current situation in this country, identifies new tools that can help d...rance, nutrition and safety at The Holland Inc., Vancouver, Wash. The paper reviews numerous aspects of food and water safety including: The current sit...Organic food not nutritionally better than conventionally-produced food
...th and nutrition benefits, and the global organic food market was estimated in 2007 to be worth 29 billion (2 billion in the UK alone). Some previous reviews have concluded that organically produced food has a superior nutrient composition to conventional food, but there has to-date been no systematic revie...DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments
PRINCETON, N.J., May 15 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biopharmaceutical company, today announced its financial results for the first quarter of 2009. DOR's revenues for the first quarter of 2009 were approximately ...CBDM.T, The Market and Business Intelligence Company Reviews The Vaccine Market
According to CBDM.T®, the market and business intelligence company, the vaccine market is a huge and growing market valued at 16 billion in 2008 with an annual growth of about 15 to 18%. The vaccine market could account for more than 25 billion by 2012. Paris, Franc...DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments
PRINCETON, N.J., March 31 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biopharmaceutical company, today announced its financial results for 2008. DOR's revenues for 2008 were approximately $2.3 million compared to $1.3 million in...RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference
BOSTON, March 17 /PRNewswire/ -- RainDance Technologies, Inc., a privately held provider of innovative microdroplet-based solutions for human health and disease research, today announced it will be shipping its first commercial Sequence Enrichment Solution this month and reviewed the company's opp...Board Reviews Strategic Options to Present to Shareholders at Shareholders' Meeting
REINACH, Switzerland, March 17 /PRNewswire-FirstCall/ -- In their press release of 25 February 2009, Arpida communicated that the Board of Directors was in the process of reviewing all the options for the company's future. In preparation of the shareholders' meeting on 7 May 2009, the B...Nature Reviews Publishes Article About Jennerex's Multi-Mechanistic Cancer Therapeutic
SAN FRANCISCO, Feb. 10 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Canada) a clinical-stage biopharmaceutical company, announced today that the journal, Nature Reviews Cancer, has published an article about the company's promising, targeted and armed oncolytic poxviruses, whi...Neurobiology of Alzheimer's Disease from Promega
Description:... D. Dawbarn and S.J. Allen (1995) This book contains up to date reviews by world authorities on current issues relating to the aetiology and treatment for Alzheimer's disease. Several major advances have been made recently...